GIB
CGI Inc.
GIB's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over GIB overall, supported by stronger valuation and stronger modeled upside.
GIB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Healthy |
GIB's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
GIB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 14x | $81.81 | — |
| Cheap | 17x | $97.00 | +19% |
| Fair | 20x | $114 | +39% |
| Expensive | 22x | $127 | +55% |
Historical ranges are pointers, not guarantees.
GIB's PE is 14x, but its earnings don't support one, so it isn't a reliable read right now.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over GIB in the historical PE scenario, which offers more potential upside but is not a forecast.
GIB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect GIB's earnings to grow and its profitability to improve, with its revenue holding steady.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
GIB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $5.67 | +7.2% |
| Q1 2026 | $5.39 | +0.7% |
| Q4 2025 | $5.24 | -1.3% |
| Q3 2025 | $5.16 | +0.4% |
| Q2 2025 | $5.29 | +5% |
| Q1 2025 | $5.35 | +8.5% |
| Q4 2024 | $5.31 | +8.8% |
| Q3 2024 | $5.14 | +6.4% |
GIB earned $5.67 per share over the past year, up 7.2% from the year before.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over GIB on earnings, with more consistent year-over-year improvement.
GIB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.9B | +2.5% |
| Q1 2026 | $2.9B | +3.3% |
| Q4 2025 | $2.9B | +7.7% |
| Q3 2025 | $2.8B | +9.7% |
| Q2 2025 | $2.9B | +11% |
| Q1 2025 | $2.8B | +7.6% |
| Q4 2024 | $2.7B | +5.1% |
| Q3 2024 | $2.6B | +4.4% |
GIB's revenue has grown year over year for 20 quarters in a row: $2.9B last quarter, up 2.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 16% | 0 points |
| Q1 2026 | 17% | +0.1 points |
| Q4 2025 | 16% | -0.1 points |
| Q3 2025 | 33% | +17 points |
| Q2 2025 | 16% | -0.1 points |
| Q1 2025 | 17% | -0.3 points |
| Q4 2024 | 16% | +0.2 points |
| Q3 2024 | 16% | +16 points |
GIB's operating margin was 16% last quarter, about level with the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over GIB on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over GIB on profitability, with a higher operating margin.
GIB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $374.2M | +30% |
| Q1 2026 | $295.6M | +15% |
| Q4 2025 | $568.2M | +38% |
| Q3 2025 | $423M | +5.1% |
| Q2 2025 | $288.9M | -4.1% |
| Q1 2025 | $257.5M | -14% |
| Q4 2024 | $411.6M | +14% |
| Q3 2024 | $402.6M | +4.8% |
GIB's free cash flow has been positive every quarter for seven years: $1.7B over the past year, up 22% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over GIB on cash flow, with more consistent year-over-year improvement.
GIB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2% | -4.3M shares |
| 1 year | -6.9% | -15.5M shares |
| 3 years | -12% | -28M shares |
| 5 years | -16% | -40.7M shares |
| Available history | -23% | -63.5M shares |
GIB has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $329.6M |
| Q1 2026 | $279.7M |
| Q4 2025 | $418.9M |
| Q3 2025 | $345M |
| Q2 2025 | $201.2M |
| Q1 2025 | $242.3M |
| Q4 2024 | $116.9M |
| Q3 2024 | $34.7M |
GIB spent $1.4B buying back its own shares over the past year, up 131% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
GIB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 1.2x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.4x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 1.1x | Healthy |
| Q1 2025 | 1.1x | Healthy |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | 0.7x | Very low |
GIB's net debt is about 1.2 years of its operating earnings (EBITDA), up from 1.1 years a year ago.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over GIB on leverage, with a lower net debt burden relative to earnings.
GIB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.0 | Neutral |
| Stochastic | 91.1 | Overbought |
GIB's weekly RSI is 61 (neutral) and its Stochastic is 91 (overbought).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
GIB PE vs Technology Sector
| Metric | GIB | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 28x | 48% below |
| PE % | 11 | 35 | 24 pts below |
GIB has the edge over NVDA on valuation relative to its sector.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
GIB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $76.4 | 7.1% above |
| 20 week MA | $73.2 | 12% above |
| 50 week MA | $75.4 | 8.6% above |
| 100 week MA | $88.2 | 7.2% below |
| 200 week MA | $96.2 | 15% below |
GIB has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
GIB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $84.1 | $79.4 | -5.6% |
| 2021 | $79.4 | $87.3 | +10% |
| 2022 | $87.3 | $85.9 | -1.5% |
| 2023 | $85.9 | $107.2 | +25% |
| 2024 | $107.2 | $109.9 | +2.5% |
| 2025 | $109.9 | $93.8 | -15% |
| 2026 YTD | $93.8 | $81.8 | -13% |
GIB has finished lower in three of the last six years. It's down 13% so far in 2026.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over GIB on returns for 2026, with the stronger performance.